Actively Recruiting

Age: 1Month - 18Years
All Genders
ID03419260

Electrographic Seizure Management and Neurobehavioral Outcomes in Critically Ill Children

Led by Children's Hospital of Philadelphia · Updated on 2025-02-04

2500

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

Sponsors

C

Children's Hospital of Philadelphia

Lead Sponsor

N

National Institute of Neurological Disorders and Stroke (NINDS)

Collaborating Sponsor

AI-Summary

What this Trial Is About

Electrographic seizures frequently occur in critically ill children and often require continuous EEG monitoring, which uses significant resources. Researchers are studying these seizures to identify risk factors and improve management strategies, as current data on the best anti-seizure medications and approaches is limited. This single-center observational study takes place at the Children's Hospital of Philadelphia and aims to create prediction models to guide EEG monitoring and evaluate the safety of current seizure management. Participants in this study are critically ill children in the Pediatric ICU undergoing clinically indicated continuous EEG monitoring. The study observes their electrographic seizure management practices following the hospital's ICU EEG Monitoring Pathway. There are no experimental treatments; instead, the study tracks EEG monitoring and seizure interventions as they naturally occur to collect data on risk factors and safety. During the study, children receive clinically required EEG monitoring and seizure management as part of their care. Researchers collect data on seizure occurrence over three days and monitor safety outcomes such as mortality, cardiopulmonary effects, organ dysfunction, and hospital-acquired infections over five days. The study does not interfere with treatment and focuses on understanding seizure risks and management outcomes over the observation period.

CONDITIONS

Brief Title

Electrographic Seizure Management and Neurobehavioral Outcomes in Critically Ill Children

Who Can Participate

Age: 1Month - 18Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Care in the Children's Hospital of Philadelphia Pediatric ICU
  • Clinically indicated continuous EEG monitoring
  • Age greater than 1 month and up to 18 years
Not Eligible

You will not qualify if you...

  • Admitted for Phase 2 (intracranial) EEG monitoring
  • Intensivist expects to discontinue technological support in the next two days due to underlying medical or neurological problems

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

Monitoring

Duration - Up to 5 days

Participants undergo clinically indicated continuous EEG monitoring to identify electrographic seizures and assess seizure risk factors.

Continuous monitoring during ICU stay

Surveillance

Duration - Up to 5 days

Participants are observed for safety outcomes including mortality, cardiopulmonary adverse effects, organ dysfunction, and hospital-acquired infections.

Trial Site Locations

Total: 1 location

1

Children's Hospital of Philadelphia

Philadelphia, Pennsylvania, United States, 19104

Actively Recruiting

Loading map...

Research Team

N

Nicholas S Abend, MD

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Similar Trials

buRst-supprESsion TO Stop Refractory Status Epilepticus Post...

Hypoxia-Ischemia, Brain

Actively Recruiting

1 location

Connectivity and Neural Signatures of Consciousness In Unres...

Acute Brain Injury

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial